The Advanced Lupus Test
Powered by CB-CAPs Technology
AVISE® Lupus is a 10-marker diagnostic test containing Cell-Bound Complement Activation Products (CB-CAPs) and other SLE associated markers designed to aid healthcare providers in a timely differential diagnosis of SLE.
|Test Components||AVISE Lupus||AVISE CTD|
|10-marker Lupus diagnostic test containing Cell-Bound Complement Activation Products (CB-CAPs)||X||X|
|AVISE Index Calculation Value||X||X|
|Extractable Nuclear Antigen (ENA) Panel||X|
|Rheumatoid Arthritis Panel||X|
|Antiphospholipid Syndrome – APS panel||X|
Specialized Lupus biomarkers contained in AVISE Lupus:
AVISE® Lupus contains patented Lupus (SLE) biomarkers, CB-CAPs, which help to offer a 22% greater sensitivity than C3/C4, and 48% greater sensitivity than anti-dsDNA.
Clinical Utility: AVISE Lupus Test
The AVISE Lupus test is an ideal test for ANA positive patients with a clinical suspicion of lupus.
Testing method: The AVISE Lupus test is composed of a two-tier multi-analyte algorithm to help facilitate evaluation of CTDs. 1,2
- Cell-bound complement activation products in SLE. Ramsey-Goldman R, et al. Lupus Science and Medicine. 2017.
- Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements. Putterman C. et al. Lupus Science and Medicine. 2014.
- Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products. Wallace D. et al. Lupus Science & Medicine. 2016.
- The AVISE Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus. Mossell J. et al. The Open Rheumatology Journal. 2016.
You deserve quality test results you can trust. Order your AVISE Testing Starter Kit today!
To order your test kits please fill out the information below.